SELLAS Life Sciences (SLS) Tax Provisions (2013 - 2019)
SELLAS Life Sciences (SLS) reported Tax Provisions of -$81000.0 for Q4 2019, up 94.74% year-over-year from -$41593.1 in Q4 2018, and up 94.74% quarter-over-quarter from -$1.5 million in Q4 2018.
SELLAS Life Sciences (SLS) Tax Provisions (2013 - 2019) Analysis & Trends
SELLAS Life Sciences (SLS) has 4 years of Tax Provisions data on file, last reported at -$81000.0 in Q4 2019.
- Tax Provisions for Q4 2019 came in at -$81000.0, up 94.74% year-over-year; the trailing twelve-month figure through Dec 2019 was -$1.6 million (down 24.29% YoY), and the FY2021 annual result was -$237000.0, down 1294.12% from the prior year.
- Tax Provisions advanced to -$81000.0 in Q4 2019 per SLS's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Tax Provisions peaked at $163000.0 in Q2 2018 and troughed at -$1.5 million in Q4 2018.
- A 3-year average of -$201000.0 and a median of $68000.0 in 2017 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2018 and 2019: Tax Provisions slumped 2210.96% in 2018, then jumped 94.74% in 2019.
- A 3-year view of Tax Provisions shows it stood at $73000.0 in 2017, then tumbled by 2210.96% to -$1.5 million in 2018, then jumped by 94.74% to -$81000.0 in 2019.
- Business Quant data shows SLS's Tax Provisions at -$81000.0 in Q4 2019, -$1.5 million in Q4 2018, and $163000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -81,000.00 |
| Dec 31, 2018 | -1.54 Mn |
| Jun 30, 2018 | 163,000.00 |
| Dec 31, 2017 | 73,000.00 |
| Sep 30, 2017 | 63,000.00 |
| Jun 30, 2017 | 117,000.00 |
| Dec 31, 2013 | 1.11 Mn |
| Sep 30, 2013 | 1.16 Mn |
| Jun 30, 2013 | 1.54 Mn |
| Mar 31, 2013 | -2.76 Mn |